Cardiovascular Systems (CSII) Reports In-Line Q3 EPS, Offers Q4 Guidance

Cardiovascular Systems (NASDAQ: CSII) reported Q3 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $47 million versus the consensus estimate of $46.84 million.

Cardiovascular Systems sees Q4 2015 EPS of ($0.28)-($0.31), versus the consensus of ($0.29). Cardiovascular Systems sees Q4 2015 revenue of $49-50.5 million, versus the consensus of $50.65 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Home Depot beats estimates, reaffirms fiscal 2026 guidance